The Ecstasy and Related Drugs Reporting System (EDRS) is an illicit drug monitoring system which has been conducted in all states and territories of Australia since 2003, and forms part of Drug Trends.

In 2023, we have provided a suite of products with the most up-to-date findings from interviews conducted annually from 2003 to 2023 with a cross-sectional sentinel group of people who regularly use ecstasy and other stimulants recruited from Sydney, New South Wales.

This includes:

1. A report overviewing the key findings in 2023;
2. An infographic summarising key findings in 2023;
3. The executive summary, summarising key findings in 2023 and
4. Supplementary data tables, providing detailed findings underlying the tables and figures within the report

Results are not representative of all consumers or drug use in the general population and should be interpreted alongside findings from other data sources for a more complete profile of emerging trends in illicit drug use in Australia.

Recommended citation

Chandrasena U, Peacock A, & Sutherland R. New South Wales Drug Trends 2023: Key Findings from the Ecstasy and Related Drugs Reporting System (EDRS) Interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2023.

Participants

We would like to thank all the participants who shared their knowledge and experience with us in the present and in previous years.

Funding

Drug Trends is supported by funding from the Australian Government Department of Health and Aged Care under the Drug and Alcohol Program.  

Copyright

Please note that any presentation of these data should include an acknowledgement of Drug Trends at the National Drug and Alcohol Research Centre, University of New South Wales. 

©NDARC, UNSW SYDNEY 2023

This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. All other rights are reserved. Requests and enquiries concerning reproduction and rights should be addressed to the information manager, NDARC, UNSW Sydney, NSW 2052, Australia via drugtrends@unsw.edu.au.

ISSN: 2981-9709

• NSW EDRS 2023 - Report, opens in a new window
• NSW EDRS 2023 - Infographics, opens in a new window
• NSW EDRS 2023 - Executive Summary, opens in a new window
• NSW EDRS 2023 - Figure Data, opens in a new window